Clinical training for regulated prescribers on psychedelic-assisted care, covering screening, contraindications, medication management, dosing, and Canadian prescribing pathways. The course combines self-paced content with a short live component and is offered in psilocybin or MDMA tracks.
Therapsil
English
8 hours total
Psychedelic Prescriber Training is a clinically focused masterclass for physicians and nurse practitioners working in regulated medical settings. It is designed to build practical understanding of prescribing pathways, risk mitigation, and the Canadian regulatory context for psychedelic-assisted psychotherapy. The curriculum covers neurobiology and neuropharmacology, dosing, evidence appraisal, drug interactions, contraindications, adverse events, patient populations, and special medical considerations. It also addresses TheraPsil roles, assessment and referral, SAP pathways, Section 56 considerations, documentation, and collaboration with care teams. The format is fully online and combines pre-readings, training videos, a live seminar, a live Q&A, and a short quiz. The listed time commitment is 8 hours total, and there are separate psilocybin and MDMA versions with different clinical examples and case framing.
Primarily physicians, psychiatrists, and nurse practitioners who want clinically relevant training on psychedelic-assisted prescribing. Other clinicians and allied professionals may enroll for education.
Built primarily for regulated medical prescribers (MD, NP).
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
By Phoenix Academy
Online course in clinical psychedelic therapy covering preparation, dosing, safety, integration, and work with co-therapists and clients. Includes videos, interactive content, quizzes, and course documents.